EARNEST Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-23
| Closed | -$6K | – | 1183 |
|
|
2022
Q3 | $6K | Hold |
23
| – | – | ﹤0.01% | 741 |
|
|
2022
Q2 | $6K | Hold |
23
| – | – | ﹤0.01% | 766 |
|
|
2022
Q1 | $8K | Hold |
23
| – | – | ﹤0.01% | 722 |
|
|
2021
Q4 | $8K | Hold |
23
| – | – | ﹤0.01% | 748 |
|
|
2021
Q3 | $7K | Hold |
23
| – | – | ﹤0.01% | 775 |
|
|
2021
Q2 | $7K | Hold |
23
| – | – | ﹤0.01% | 778 |
|
|
2021
Q1 | $7K | Hold |
23
| – | – | ﹤0.01% | 754 |
|
|
2020
Q4 | $7K | Hold |
23
| – | – | ﹤0.01% | 735 |
|
|
2020
Q3 | $6K | Hold |
23
| – | – | ﹤0.01% | 728 |
|
|
2020
Q2 | $6K | Hold |
23
| – | – | ﹤0.01% | 708 |
|
|
2020
Q1 | $3K | Hold |
23
| – | – | ﹤0.01% | 855 |
|
|
2019
Q4 | $4K | Hold |
23
| – | – | ﹤0.01% | 879 |
|
|
2019
Q3 | $4K | Hold |
23
| – | – | ﹤0.01% | 852 |
|
|
2019
Q2 | $6K | Hold |
23
| – | – | ﹤0.01% | 734 |
|
|
2019
Q1 | $7K | Hold |
23
| – | – | ﹤0.01% | 665 |
|
|
2018
Q4 | $7K | Hold |
23
| – | – | ﹤0.01% | 639 |
|
|
2018
Q3 | $10K | Hold |
23
| – | – | ﹤0.01% | 590 |
|
|
2018
Q2 | $9K | Buy |
23
+11
| +92% | +$4.3K | ﹤0.01% | 617 |
|
|
2018
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 952 |
|
|
2017
Q4 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 1044 |
|
|
2017
Q1 | – | Sell |
-12
| Closed | -$1K | – | 983 |
|
|
2016
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1095 |
|